Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor | Patent Number 09539251

US 09539251 B2
Application Number14020761
Publication NumberUS 20140248262 A1
Pendency3 years, 4 months, 7 days
Filled DateSep 6, 2013
Priority DateSep 7, 2012
Publication DateSep 4, 2014
Expiration DateSep 6, 2032
Inventor/ApplicantsChristian Klein
Deepak Sampath
Wayne John Fairbrother
ExaminesXIAO, YAN
Art Unit1642
Technology Center1600
Assignments
Abbvie Inc.
Current
Genentech Inc
Current
Genentech IncRoche
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.